Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Mika123on Sep 25, 2020 12:40pm

138 Views

Post# 31620569

RE:RE:RE:RE:ViaCyte CEO Retired Sept 2020; no replacement so far

on this point i fully agree bio. sernova needs a collaboration and money from big pharma as a catalyst to finally boost the price and kick these manipulators out as well. sva is not a mass-produced paper. only a small group of people around the world is invested here and that is not enough to generate trade and push the SP. The Cell Pouch does not serve any hype topics such as corona, cancer, hydrogen or electromobility. diabetes is a world problem yes. but nobody has it on the screen.

Bullboard Posts

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures